Mardi 9 Février

Retour à la vue des calendrier
Mardi 9 Février
Heure: 13:00 - 14:00
Lieu: Séminaire en ligne.
Résumé: MB - Personalised risk predictor for acute cellular rejection in lung transplantation -
Description: Ian Morilla & Alexy Tran DinhLung transplantation is the treatment of last resort that may be offered
to selected patients with end-stage pulmonary disease. Acute cell
rejection (ACR) is common complication that have nearly the 30% of lung
transplant recipients within the first year of follow-up. The
development of surrogate markers that could help identify recipients at
risk of developing ACR would be a major diagnostic aid to the clinician.
CD31, the receptor most represented on the endothelial surface, is
cleaved and released into the plasma upon endothelial activation and is
therefore a powerful biomarker of endothelial dysfunction.